Drug Pipeline

Pelareorep Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
2
Top Sponsors
Active Studies by Phase
Phase 2
1
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07446322 FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of… Ras-mutated Metastatic Colorectal Cancer Recruiting
Phase 1/2
NCT05514990 Bortezomib and Pembrolizumab With or Without Pelareorep for the Treatment of Relapsed or… Recurrent Plasma Cell Myeloma Active, Not Recruiting
NCT07280377 A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment… Anal Cancer Metastatic Active, Not Recruiting
Sponsors Running Pelareorep Trials
Oncolytics Biotech (2) University of Southern California (1)
Disease Areas
Multiple Myeloma (1) Pancreatic Cancer (1) Colorectal Cancer (1)
Get alerts when Pelareorep trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free